Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 711-720 of 744 for

Edit search filters
  1. IRB#21-009968: Assessing the Sexual Health and Well-Being of Female Survivors of Pelvic Malignancies after Radiotherapy

    Rochester, MN

  2. Assessment of the Safety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant Systemic Therapy and Surgery, UTMOST Trial

    Rochester, MN

  3. A Study to Evaluate Brain Natriuretic Peptides for the Avoidance of Treatment-Related Heart Failure in Breast Cancer Survivors

    Rochester, MN

  4. A Study Of Chemotherapy Selection For PM For Colorectal And Appendiceal Cancers

    Rochester, MN

  5. A Study To Evaluate Diarrhea In Patients With Multiple Myeloma Receiving Conditioning Chemotherapy For Autologous Stem Cell Transplantation (SCT)

    Rochester, MN

  6. Kinetics of Troponin and BNP in Breast Cancer Chemotherapy with Adriamycin and Trastuzumab

    Jacksonville, FL

  7. A Study To Evaluate Family Member Exposure To Antineoplastic Drugs In The Home Setting

    Eau Claire, WI

  8. DNA Damage Using HERY-MNT Technology Can Predict Chemotherapy Induced Toxicity In Women With Ovarian Cancer

    Rochester, MN

  9. Breast Cancer: Can We Predict Pathological Complete Response following Neoadjuvant Treatment?

    Scottsdale/Phoenix, AZ

  10. A Study to Determine the Effects of COVID-19 in Cancer Patients

    Scottsdale/Phoenix, AZ, Mankato, MN, La Crosse, WI, Eau Claire, WI, Rochester, MN

.

Mayo Clinic Footer